Cargando…

Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy

Objective: The purpose of this study was to investigate the effect of dapagliflozin (DAPA), a sodium-glucose cotransporter 2 inhibitor, on relieving cardiac hypertrophy and its potential molecular mechanism. Methods: Cardiac hypertrophy induced by abdominal aortic constriction (AAC) in mice, dapagli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jing, Zhao, Huanhuan, Qi, Xin, Wei, Liping, Li, Zihao, Li, Chunpeng, Zhang, Xiaoying, Wu, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495133/ https://www.ncbi.nlm.nih.gov/pubmed/34630108 http://dx.doi.org/10.3389/fphar.2021.730623

Ejemplares similares

Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Liu, Zengying, et al.
Publicado: (2022)

Metformin Attenuates Cardiac Hypertrophy Via the HIF-1α/PPAR-γ Signaling Pathway in High-Fat Diet Rats
por: Liu, Yuansheng, et al.
Publicado: (2022)

Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism
por: Zhang, Xiaoying, et al.
Publicado: (2021)

UVA Induced Oxidative Stress Was Inhibited by Paeoniflorin/Nrf2 Signaling or PLIN2
por: Lu, Yan-Song, et al.
Publicado: (2020)

Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
por: Zhen, Changlin, et al.
Publicado: (2023)

Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
por: Aiyasiding, Xiahenazi, et al.
Publicado: (2022)

Selective Inhibition of the Immunoproteasome β5i Prevents PTEN Degradation and Attenuates Cardiac Hypertrophy
por: Xie, Xin, et al.
Publicado: (2020)

RXRα Positively Regulates Expression of the Chicken PLIN1 Gene in a PPARγ-Independent Manner and Promotes Adipogenesis
por: Sun, Yuhang, et al.
Publicado: (2020)

Quercetin Attenuates Cardiac Hypertrophy by Inhibiting Mitochondrial Dysfunction Through SIRT3/PARP-1 Pathway
por: Chen, Wen-Jing, et al.
Publicado: (2021)

Triptolide Upregulates Myocardial Forkhead Helix Transcription Factor p3 Expression and Attenuates Cardiac Hypertrophy
por: Ding, Yuan-Yuan, et al.
Publicado: (2016)

Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload
por: Zhang, Nan, et al.
Publicado: (2021)

Dapagliflozin Promotes Neovascularization by Improving Paracrine Function of Skeletal Muscle Cells in Diabetic Hindlimb Ischemia Mice Through PHD2/HIF-1α Axis
por: Nugrahaningrum, Dyah Ari, et al.
Publicado: (2020)

High-Salt Attenuates the Efficacy of Dapagliflozin in Tubular Protection by Impairing Fatty Acid Metabolism in Diabetic Kidney Disease
por: Zou, Meina, et al.
Publicado: (2021)

Trimetazidine Ameliorates Myocardial Metabolic Remodeling in Isoproterenol-Induced Rats Through Regulating Ketone Body Metabolism via Activating AMPK and PPAR α
por: Li, Huihui, et al.
Publicado: (2020)

Cigarette Smoking-Induced Cardiac Hypertrophy, Vascular Inflammation and Injury Are Attenuated by Antioxidant Supplementation in an Animal Model
por: Al Hariri, Moustafa, et al.
Publicado: (2016)

PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice
por: Guo, Fusheng, et al.
Publicado: (2020)

Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
por: Chen, Yan, et al.
Publicado: (2022)

A CRM1 Inhibitor Alleviates Cardiac Hypertrophy and Increases the Nuclear Distribution of NT-PGC-1α in NRVMs
por: Liu, Zuheng, et al.
Publicado: (2019)

Novel Sulfur Metabolites of Garlic Attenuate Cardiac Hypertrophy and Remodeling through Induction of Na(+)/K(+)-ATPase Expression
por: Khatua, Tarak N., et al.
Publicado: (2017)

Signaling via the Interleukin-10 Receptor Attenuates Cardiac Hypertrophy in Mice During Pressure Overload, but not Isoproterenol Infusion
por: Stafford, Nicholas, et al.
Publicado: (2020)

Dapagliflozin Attenuates Myocardial Fibrosis by Inhibiting the TGF-β1/Smad Signaling Pathway in a Normoglycemic Rabbit Model of Chronic Heart Failure
por: Chen, Xuefeng, et al.
Publicado: (2022)

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
por: Peng, Kesong, et al.
Publicado: (2016)

Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway
por: Zhao, Tingwei, et al.
Publicado: (2021)

HMGB1 Is Involved in the Protective Effect of the PPARα Agonist Fenofibrate against Cardiac Hypertrophy
por: Jia, Zhankui, et al.
Publicado: (2014)

Plin5/p-Plin5 Guards Diabetic CMECs by Regulating FFAs Metabolism Bidirectionally
por: Du, Jin, et al.
Publicado: (2019)

Emerging Therapeutic Role of PPAR–α in Cognition and Emotions
por: Nisbett, Khalin E., et al.
Publicado: (2018)

PPARα: A potential therapeutic target of cholestasis
por: Ye, Xiaoyin, et al.
Publicado: (2022)

FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway
por: Zhuang, Lingfang, et al.
Publicado: (2021)

Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα
por: Sun, Ying, et al.
Publicado: (2018)

Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ
por: Zhu, Ya-Di, et al.
Publicado: (2021)

Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
por: Qiao, Panshuang, et al.
Publicado: (2022)

An RDH‐Plin2 axis modulates lipid droplet size by antagonizing Bmm lipase
por: Zhao, Xuefan, et al.
Publicado: (2022)

Energy Metabolism in Exercise-Induced Physiologic Cardiac Hypertrophy
por: Xiang, Kefa, et al.
Publicado: (2020)

SGLT1 Knockdown Attenuates Cardiac Fibroblast Activation in Diabetic Cardiac Fibrosis
por: Lin, Hui, et al.
Publicado: (2021)

Dapagliflozin versus empagliflozin in patients with chronic kidney disease
por: Alnsasra, Hilmi, et al.
Publicado: (2023)

SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
por: Li, Zhenzhen, et al.
Publicado: (2019)

Dapagliflozin Protects Methamphetamine-Induced Cardiomyopathy by Alleviating Mitochondrial Damage and Reducing Cardiac Function Decline in a Mouse Model
por: He, Shanqing, et al.
Publicado: (2022)

TRPC5-eNOS Axis Negatively Regulates ATP-Induced Cardiomyocyte Hypertrophy
por: Sunggip, Caroline, et al.
Publicado: (2018)

Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions
por: Liu, Ya, et al.
Publicado: (2021)

TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR-δ Upregulation
por: Gao, Feng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dui4hlvo4nd7bjr40c8h6s5j15